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A previously uncharacterized putative ion channel, NALCN
(sodium leak channel, non-selective), has been recently shown
to be responsible for the tetrodotoxin (TTX)-resistant sodium leak
current implicated in the regulation of neuronal excitability.
Here, we show that NALCN encodes a current that is activated by
M3 muscarinic receptors (M3R) in a pancreatic b-cell line. This
current is primarily permeant to sodium ions, independent of
intracellular calcium stores and G proteins but dependent on Src
activation, and resistant to TTX. The current is recapitulated by
co-expression of NALCN and M3R in human embryonic kidney-
293 cells and in Xenopus oocytes. We also show that NALCN and
M3R belong to the same protein complex, involving the
intracellular I–II loop of NALCN and the intracellular i3 loop of
M3R. Taken together, our data show the molecular basis of a
muscarinic-activated inward sodium current that is independent
of G-protein activation, and provide new insights into the
properties of NALCN channels.
Keywords: ion channel; G proteins; M3 muscarinic receptor;
NALCN; Src
EMBO reports (2009) 10, 873–880. doi:10.1038/embor.2009.125
INTRODUCTION
Ion channels are crucial components for cell excitability. They are
involved in numerous physiological processes, as well as in
pathologies referred to as channelopathies, and are drug targets of
interest (Ashcroft, 2006; Kaczorowski et al, 2008). In 1999, Lee
et al (1999) reported the cloning of a new putative ion channel
mainly expressed in the brain and, to a lesser extent, in the heart
and pancreas (supplementary Fig S1A,B online). The correspond-
ing protein, NALCN (sodium leak channel, non-selective), is
highly homologous to the voltage-gated sodium channel-a and
calcium channel-a1 pore-forming subunits (Snutch & Monteil,
2007). Recently, Lu et al (2007) provided evidence that NALCN is
responsible for a tetrodotoxin (TTX)-resistant sodium leak current
implicated in neuronal excitability by generating knockout mice
and overexpressing the corresponding complementary DNA
(cDNA) in human embryonic kidney (HEK)-293 cells. In addition,
the same group also reported a modulation of NALCN by
substance P and neurotensin through a G-protein-independent
and Src family of tyrosine kinases (SFKs)-dependent pathway
(Lu et al, 2009).
We independently set out to characterize NALCN channel
activity. In this study, we used both overexpression and knock-
down approaches in the MIN6 pancreatic b-cell line, which
endogenously expresses NALCN. After initial experiments, we did
not detect any evidence of leak activity mediated by NALCN in
this cellular model (supplementary Fig S2 online). We then
investigated the possibility that NALCN could encode another
type of current in these cells. Here, we report that in MIN6 cells,
NALCN encodes an inward cationic channel activated by
acetylcholine through the activation of M3 muscarinic receptors
(M3R). Similar to the leak current observed by Lu et al (2007), the
M3R-activated NALCN current observed in MIN6 cells is
primarily mediated by sodium ions, is resistant to TTX and is
sensitive to gadolinium ions. This current was recapitulated in the
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873HEK-293 cell line as well as in Xenopus oocytes, and involves the
inclusion of both NALCN and M3R in a protein complex. Thus,
this study provides new insights into the complexity of NALCN
gating properties.
RESULTS
Knockdown and overexpression of NALCN in MIN6 cells
To facilitate the study of NALCN, we screened pancreatic b-cell
lines for its expression using reverse transcription quantitative PCR
(RT–qPCR) and western blot analysis because expression of the
corresponding messenger RNA (mRNA) was detected in islets of
Langerhans (supplementary Fig S1B online). We observed robust
expression in the MIN6 pancreatic b-cell line (Fig 1A,B). Owing to
NALCN’s apparent voltage independence and the lack of any leak
activity in our experimental conditions, we decided to investigate
‘orphan’ currents—that is, a current of unknown molecular
identity—activated by means other than changes in membrane
potential in pancreatic b-cells and related cell lines. Primary
pancreatic b-cells have been reported to have an inward sodium
conductance of unknown molecular origin activated by muscarinic
acetylcholine receptors (MRs), without G-protein involvement
(Rolland et al, 2002). In keeping with these observations,
application of acetylcholine (100mM) to MIN6 pancreatic
b-cells held at  80mV in a standard whole-cell voltage-clamp
Control
NALCN-sh1
NALCN-sh2
NALCN++
350
300
250
200
A
C
h
 
c
u
r
r
e
n
t
 
d
e
n
s
i
t
y
(
%
 
c
o
n
t
r
o
l
)
150 (34)
(10)
*
(8)
*
(18)
*
100
50
0
E
ACh 100 μM:
Atropine 10 μM:
0 pA
ACh 100 μM:
Atropine 10 μM:
0 pA
10 pA
30 s
10 pA
1 s
C
wt-HEK-293
NALCN
wt-MIN6
Control
NALCN-sh1
NALCN-sh2
kDa
150 α-NALCN
50 α-Tubulin
HEK-293 MIN6
B
wt-MIN6
Control
NALCN-sh1
NALCN-sh2
0
25
50
P
e
r
c
e
n
t
a
g
e
 
o
f
β
2
-
m
i
c
r
o
g
l
o
b
u
l
i
n
 
(
%
)
75
100
125 A
20 pA
10 s
20 pA
10 s
20 pA
10 s
20 pA
0 pA
0 pA
0 pA
0 pA
10 s
Control
100 μM ACh
NALCN-sh1
NALCN-sh2
NALCN++
D
Fig 1 |Knockdown and overexpression of NALCN in MIN6 cells alter an atropine-sensitive acetylcholine-activated current. (A) Endogenous NALCN
expression in MIN6 cells assessed by RT–qPCR (data are presented as a percentage of expression compared with the b2M level) and (B) western blot
analysis in the absence and presence of shRNAs. (C) Representative sample of acetylcholine (ACh) activated current on a MIN6 pancreatic b-cell held
at  80mV in a standard whole-cell voltage-clamp configuration. (D) This current is substantially reduced with shRNA targeted against NALCN and
increased with NALCN overexpression. (E) Summary of the effects of NALCN shRNA knockdown and overexpression on acetylcholine current density,
expressed as a percentage of mean control-cell current. NALCN, sodium leak channel, non-selective; RT–qPCR, reverse transcription quantitative PCR;
shRNA, short hairpin RNA.
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874configuration activated an atropine-sensitive inward current with
a mean current density of  7.7±0.9pA/pF (N¼34; Fig 1C). This
current was found to show some desensitization during acetylcho-
line application (Fig 1C,D). We therefore used both NALCN
knockdown and overexpression strategies to investigate the
hypothesis that NALCN encodes the observed b-cell MR-activated
sodium conductance. Using two different short hairpin RNA
(shRNA) sequences, we were able to substantially reduce the
expression of endogenous NALCN, as confirmed by RT–qPCR and
western blotting (B50% at the mRNA level, with a transduction
rate of B80%; Fig 1A,B). Acetylcholine-activated current density
in MIN6 cells was significantly reduced by NALCN-shRNA
knockdown (NALCN-sh1: 44.8±17.1% of control, N¼10,
P¼0.03; NALCN-sh2: 43.1±9.3% of control, N¼8, P¼0.02;
Fig 1D,E), and was increased by NALCN overexpression
(260.2±62.1% of control, N¼18, P¼0.02; Fig 1D,E). Taken
together, these results suggest that application of acetylcholine
induces an inward cationic current through activation of NALCN.
Permeation and gating properties in MIN6 cells
We then examined some of the ion permeation and gating
properties of the acetylcholine-activated current in MIN6 cells.
Substitution of sodium ions by N-methyl-D-glucamine or lithium
in the extracellular solution had a robust inhibitory effect,
suggesting that sodium is the main ion species contributing to
the NALCN inward conductance (21.4±9.4% of control, N¼5,
P¼0.001 and 53.2±9.7% of control, N¼5, P¼0.008, respec-
tively; Fig 2A). The current was also insensitive to TTX (2mM;
103.3±9.8% of control, N¼7; Fig 2A), but was partly blocked by
gadolinium (10mM; 51.4±6.1% of control, N¼9, Po0.0001;
Fig 2A). Addition of heparin (1mg/ml) to the patch pipette did not
affect the current density, indicating that the current was
independent of intracellular calcium stores mobilized through
activation of IP3 receptors (97.1±22.2% of control, N¼12,
P¼0.89; Fig 2A). Replacement of GTP with either GDP-b-S
(1mM) or GTP-g-S (1mM) in the pipette solution did not
significantly change the current density (72.3±18.7% of control,
N¼9, P¼0.178, and 86±23.8% of control, N¼7, P¼0.579,
respectively; Fig 2A). Even the use of a pipette solution with no
GTP did not have any effect on the current (data not shown). It has
been shown that some G-protein-coupled receptors (GPCRs) can
signal directly through SFKs (McGarrigle & Huang, 2007). Thus,
we also examined the possibility that NALCN could be activated
through an SFK-dependent pathway by using the SFK inhibitor
4-amino-5-(4-methylphenyl)-7-(t-butyl)pyrazolo[3,4-d]-pyrimidine
(PP1) (Fig 2A,B). Bath application of PP1 (20mM) almost fully
and reversibly abolished the acetylcholine-activated current
(6.1±2.5% of control, N¼5, Po0.0001; Fig 2A,B). A strong
inhibition was also observed with the SFK inhibitor SU6656
(20.1±11.9% of control, N¼5, P¼0.001; Fig 2A and supple-
mentary Fig S3 online). The current–voltage (I–V) relationship of
the acetylcholine-activated current was determined by using a
voltage ramp protocol in the absence and presence of acetyl-
choline (N¼8; Fig 2C). We found the relationship to be linear in
the range of  110 to  20mV, with a slope conductance of
76.8±2.5pS/pF, and a reversal potential Erev of approximately
 23mV. As the activation of the current by acetylcholine was
associated with an increase in membrane noise, we also carried
out a noise analysis to estimate the single-channel amplitude and
found a value of 1.6±0.1pA at  80mV with an estimated single-
channel conductance of B27pS (supplementary Fig S4 online).
To determine further which MRs were involved in the modulation
of NALCN, we first carried out an analysis by using RT–qPCR in
MIN6 cells (Fig 2D). Our results indicated that M3R and M4R are
the muscarinic receptor subtypes present in MIN6 cells (Fig 2D).
We therefore used specific antagonists of M3R (7mM 4-dipheny-
lacetoxy-N-methylpiperidine methiodide) and M4R (10mM
tropicamide) to determine the MR subtype responsible for
current activation (Fig 2E,F). Our results suggest that M3R was
responsible for current activation (4-diphenylacetoxy-N-methyl-
piperidine methiodide: 20.9±2.6% of control, N¼5, P¼0.0002;
tropicamide: 94.8±18.3% of control, N¼9; Fig 2F). These
data suggest that M3R activation induces an inward, primarily
sodium, conductance through NALCN channels that is
independent of intracellular calcium stores and G proteins,
dependent on SFK activation, resistant to TTX and sensitive to
gadolinium inhibition.
Heterologous co-expression of NALCN and M3R
Next we sought to address whether NALCN and M3R are
sufficient to reconstitute an acetylcholine-activated current in
two commonly used heterologous expression systems. Expression
of NALCN in HEK-293 cells stably expressing M3R, in which
NALCN is not endogenously expressed (Fig 1B and supplementary
Fig S6A online), resulted in a significant acetylcholine-activated
current with a similar profile to but of a smaller density than that
observed in MIN6 cells (NALCNþM3R  2.7±0.3pA/pF, N¼17,
P¼0.001; M3R  1.2±0.1pA/pF, N¼16; Fig 3A,B). This result
shows that M3R and NALCN are two components necessary for
recapitulating the current of interest, and suggests that additional
proteins probably modulate the channel activity and/or the
channel level at the plasma membrane in native systems. We
next examined whether the current could be recapitulated even in
Xenopus oocytes by expressing NALCN and an M3R mutant
(M3R*) lacking a stretch of 10 amino acids (YKETEKRTKE) in the i3
loop involved in G-protein activation in this cellular model
(Lechleiter et al, 1990). As expected, agonist stimulation of M3R*
did not result in the activation of a strong endogenous Ca2þ-
activated Cl  current as did M3R (Fig 3C,D). When NALCN and
M3R* were co-expressed, carbachol (100mM) application resulted
in the activation of an inward current (M3R*þNALCN
 42.3±9.9nA, N¼8, P¼0.008; Fig 3C,D), as this current was
abolished by the substitution of sodium ions using N-methyl-
D-glucamine (supplementary Fig S5 online). Interestingly, contrary
to our data for MIN6 cells, the NALCN-generated current did not
show any desensitization in HEK-293 cells or Xenopus oocytes. In
our study, the desensitization process was not found to be agonist
dependent (data not shown), suggesting that it is likely to be
cell-type dependent. We did not observe any significant effect
resulting from the expression of NALCN on the leak activity in
HEK-293 cells (NALCNþM3R  2.1±0.7pA/pF, N¼17; M3R
 2.5±0.7pA/pF, N¼16; Fig 3E) or in Xenopus oocytes (control:
 97.7±18.3nA, N¼11; NALCN:  72.3±15.6nA, N¼3; M3R:
 178.6±55.9nA, N¼5; M3R*:  264.9±72nA, N¼17; and
M3R*þNALCN:  287.5±60.6nA, N¼8; Fig 3F). Thus, we
conclude that, under our experimental conditions, NALCN did not
encode for a leak channel but for an inward cationic channel
activated by acetylcholine through M3R.
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875NALCN and M3R belong to the same protein complex
Considering that NALCN was activated by M3R but not by M4R,
whereas it has been suggested that both muscarinic receptors can
activate SFKs (Rosenblum et al, 2000), we next investigated the
hypothesis that NALCN could associate with M3R in the same
complex, thus involving a spatially localized signalling event.
Owing to the lack of available antibodies to perform immuno-
precipitation experiments from native systems, we carried out
co-immunoprecipitation experiments with haemagglutinin-tagged
NALCN and Flag-tagged M3R that were heterologously expressed
in HEK-293 cells (Fig 4A). Our results indicated that NALCN and
M3R associate with one another, whereas this is not the case with
M4R and with the b2-adrenergic receptor used as controls
(Fig 4A). It remains to be determined whether this is through a
direct interaction or through co-inclusion in a larger protein
complex. Intracellular portions of ion channels and GPCRs are
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Fig 2 |Permeation and gating properties of the acetylcholine-activated current in MIN6 cells. (A) Replacement of sodium ions by NMDG or lithium in
the extracellular solution greatly diminishes the acetylcholine (ACh)-induced inward current. The current is also resistant to 2mM TTX and was partly
blocked by 10mMG d 3þ. Inclusion of heparin (1mg/ml), GTP-g-S (1mM) or GDP-b-S (1mM) in the pipette solution does not significantly affect the
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was used to determine the current–voltage relationship of the acetylcholine-activated current. Values obtained in the absence of acetylcholine were
subtracted from values obtained in the presence of acetylcholine to determine the I–V curve attributable to acetylcholine. Currents obtained at voltages
greater than  20mV were too variable for meaningful analysis and were therefore excluded. (D) RT–qPCR analysis shows that only mRNA from M3R
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876known to be involved in protein–protein interactions in some
protein complexes (Bockaert et al, 2004; Levitan, 2006). Thus, we
next examined whether intracellular fragments of NALCN and
M3R were involved in their interaction by using GFP fusion
proteins (Fig 4B,C). We found that M3R co-immunoprecipitates
with the I–II loop of NALCN and that NALCN co-immunopreci-
pitates with the i3 loop and the carboxy-terminal portion of M3R
(Fig 4B,C). Overexpression of these intracellular fragments in
MIN6 cells showed that the I–II loop of NALCN and the i3 loop of
M3R significantly inhibited the native acetylcholine-activated
inward current, probably through uncoupling of NALCN and M3R
(loop I–II, 7.8±3.2% of control, N¼13, Po0.01; loop i3,
17.3±4.6% of control, N¼9, Po0.01; Fig 4D,E). These data
suggest that NALCN and M3R coexist in the same protein complex
and that this requires molecular determinants present in the I–II
loop of NALCN and the i3 loop of M3R.
DISCUSSION
Our data show that NALCN channels can be activated by M3R
receptors without the involvement of G proteins but through an
SFK-dependent pathway, and involves the inclusion of the two
molecules in the same protein complex. We have shown that the
resulting current is endogenous to the MIN6 pancreatic b-cell line,
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877and can be reconstituted in recombinant systems. The M3R-
mediated activation of the NALCN current possibly occurs through
a direct interaction between these proteins or through interactions
resulting from their co-assembly into a larger protein complex.
Activation of inward cationic currents similar to those observed in
this study and that do not require G-protein activation has been
previously described in native pancreatic b-cells (Rolland et al,
2002), CA3 pyramidal neurons (Guerineau et al, 1995) and cardiac
myocytes (Shirayama et al, 1993). Further studies are needed to
determine the physiological roles of NALCN in these cell types.
Our results show that M3R and NALCN are necessary for
recapitulating the native current in recombinant systems, but also
suggest that further proteins probably modulate channel activity
and/or the level of channel expression at the plasma membrane in
native systems. With respect to this idea, it is known that most ion
channels exist as heteromultimeric protein complexes in which
binding partners modulate the transport and the biophysical
properties of the pore-forming subunit (Levitan, 2006). Further
work is needed to determine the proteins that might be included in
any complex together with NALCN and M3R. One clue about
such proteins is provided by genetic evidence suggesting a
functional interaction between NALCN orthologues in inverte-
brates and two proteins named UNC-79 and UNC-80 (Humphrey
et al, 2007; Jospin et al, 2007; Yeh et al, 2008). The corresponding
mRNAs are not expressed in HEK-293 cells but are detected in
MIN6 cells and in the islets of Langerhans (supplementary
Fig S5A,B online). In addition, while this paper was under
consideration, a report by Lu et al showed that UNC-80 is required
to observe a strong modulation of NALCN activity by substance P
through neurokinin 1 receptors in HEK-293 cells (Lu et al, 2009).
Whether UNC-80 and/or UNC-79 is required in the NALCN–M3R
complex remains to be established.
It should be noted that under our experimental conditions, we
have been unable to detect any NALCN-induced leak activity in
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the M3R’s GFP-tagged intracellular segment i3 and the carboxy-terminus (Cter) part. (D) Overexpression of the NALCN’s GFP-tagged intracellular loop
I–II and (E) M3R’s GFP-tagged intracellular segment i3 in the MIN6 cell line results in a strong inhibition of the acetylcholine (ACh)-activated inward
current. GFP, green fluorescent protein; HA, haemagglutinin; HEK, human embryonic kidney; M3R, M3 muscarinic receptors; NALCN, sodium leak
channel, non-selective; WB, western blot.
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878MIN6 cells, as well as in recombinant expression systems such as
HEK-293 cells and Xenopus oocytes. Instead, we observed that
NALCN is activated by M3R in our cellular models. It is known
that GPCRs can show constitutive activity that is modulated by
factors such as binding partners (Ango et al, 2001; Milligan, 2003).
Thus, one hypothesis to explain the leak activity described by Lu
et al (2007) in neurons is that it results from constitutive activation
of NALCN by one or more GPCRs. Lu et al (2007) were also able
to record a leak current after expression of NALCN in HEK-293
cells. We, and others, have been unable to observe any leak
activity in this cell type (M. Biel, personal communication).
However, this cell line is known to show a variation in the
repertoire of expressed genes depending on the culture procedure,
passage number and sub-clone types (Thomas & Smart, 2005),
thus providing a possible explanation for this discrepancy.
In conclusion, our study indicates that NALCN is activated by
M3Rs in the MIN6 cell line and might behave as a leak channel
depending on the cellular environment. Our study provides new
insights into the properties of NALCN channels.
METHODS
Reagents. Human complementary DNAs (cDNAs) encoding wild-
type M3R, Flag-tagged M3R and Flag-tagged b2-adrenergic receptor,
as well as the pLVTHM vector were provided by Drs E. Lutz,
M. Hosey and D. Trono, respectively. All drugs were purchased from
Sigma (Saint-Quentin, Fallavier, France), with the exception of PP1
and SU6656 (Calbiochem, Nottingham, UK).
Cloning of human NALCN and antibody generation. Human
NALCN cDNA was amplified from human brain RNA using
RT–PCR (Clontech, Palo Alto, CA, USA) and cloned into
pcDNA5FRT (Invitrogen, Cergy Pontoise, France). The NALCN
rabbit polyclonal antibody was generated with a glutathione-S-
transferase fusion protein of the last 288 amino acids of NALCN
and affinity-purified.
Other constructs. Haemagglutinin-tagged human NALCN,
Flag-tagged M4R (amino terminus) and M3R* were generated by
PCR and cloned into pcDNA5FRT (Invitrogen).
Lentivirus-mediated RNA interference. The shRNAs used in
this study target sequences encoding for the III–IV linker (no
alternative splicing events detected; shRNA-1: AAGAUCGCA
CAGCCUCUUCAU; shRNA-2: AAUGUAUGACAUAACCCAGC;
and control: GCUCAGUACGAUCAUACUCAC). Corresponding
pairs of oligonucleotides were annealed and cloned in the
pLVTHM lentiviral vector. Cells were transduced at a multiplicity
of infection of 10.
Quantitative RT–PCR. DNase-treated (Ambion, Austin, TX, USA)
RNAs were reverse-transcribed using random hexameric oligo-
nucleotides and MoMuLV-RT (Invitrogen). Real-time PCR was carried
out in duplicate (7500 System; Applied Biosystems, Courtaboeuf,
France), according to the manufacturer’s instructions. Target RNA
expression level was normalized to b2-microglobulin, according to
the 2 DCt method (2 ðCtðXÞ CtðB2MÞÞ), where Ct is the threshold cycle
for the target RNA (Ct(X)) and b2-microglobulin (Ct(B2M)).
Electrophysiology. Patch-clamp measurements were carried out
in whole-cell voltage-clamp configuration (Axopatch 200B
patch clamp amplifier, Clampex9.2 software (Axon Instruments,
Molecular Devices, Wokingham, UK)). Pipettes were pulled from
borosilicate glass to give 4 6MO resistance. Acetylcholine-
activated currents were measured in cells held at  80mV at
room temperature (20–251C). The extracellular solution consisted
of NaCl 119mM, KCl 4mM, KH2PO4 1.2mM, MgSO4 1.2mM,
CaCl2 2.5mM, Na2CO3 0.42g/l, HEPES 20mM and glucose
10mM (pH 7.2 with NaOH; osmolarity approximately
290mOsm). The pipette solution consisted of K-aspartate
100mM, KCl 25mM, NaCl 10mM, Mg–ATP 2mM, Na–GTP
0.1mM, creatine phosphate 5mM, HEPES 5mM, CaCl2 0.04mM
and MgCl2 1mM (pH 7.2 with KOH; osmolarity B290mOsm).
Alterations to solutions are noted in the text and figure legends
wherever appropriate. Current amplitude was defined as peak-
current value during acetylcholine application compared with
baseline. Nuclear injection and recording of macroscopic currents
in Xenopus oocytes were carried out as reported previously
(Altier et al, 2001).
Data analysis. Data are presented as mean±s.e.m. Statistical
significance was evaluated using Student’s t-test for paired or
unpaired data (significance level 0.05). Multiple comparisons
were carried out by analysis of variance followed by Tukey’s
multiple comparison test. *Po0.05; **Po0.01; ***Po0.001.
Supplementary information is available at EMBO reports online
(http://www.emboreports.org).
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